Marshall Wace’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-10,695
Closed -$229K 2522
2024
Q2
$229K Buy
+10,695
New +$208K ﹤0.01% 2252
2022
Q2
Sell
-885,459
Closed -$20.1M 3431
2022
Q1
$20.1M Sell
885,459
-461,287
-34% -$12.1M 0.04% 495
2021
Q4
$50.2M Buy
1,346,746
+54,502
+4% +$2.34M 0.09% 209
2021
Q3
$54.7M Sell
1,292,244
-474,448
-27% -$22.8M 0.23% 73
2021
Q2
$78.6M Buy
1,766,692
+590,659
+50% +$20.8M 0.36% 50
2021
Q1
$42.3M Buy
1,176,033
+14,368
+1% +$568K 0.19% 105
2020
Q4
$46.3M Buy
+1,161,665
New +$39.6M 0.25% 82
2020
Q3
Sell
-10,034
Closed -$164K 1589
2020
Q2
$164K Sell
10,034
-73,802
-88% -$1.02M ﹤0.01% 1434
2020
Q1
$796K Buy
83,836
+37,342
+80% +$513K 0.01% 861
2019
Q4
$752K Buy
+46,494
New +$756K 0.01% 1051
2019
Q3
Sell
-42,200
Closed -$715K 1671
2019
Q2
$715K Buy
42,200
+11,922
+39% +$208K 0.01% 1010
2019
Q1
$542K Buy
30,278
+20,512
+210% +$326K 0.01% 1116
2018
Q4
$117K Buy
+9,766
New +$117K ﹤0.01% 1341

Other funds holding BLFS

Marshall Wace's BLFS Position: Q3 2024 in Review

Marshall Wace sold out of BioLife Solutions (BLFS) in Q3 2024, closing a stake of 10,695 shares — an estimated $229K sold.

Marshall Wace first reported a position in BLFS in Q4 2018 and held it in 13 quarters. The position peaked at $78.6M in Q2 2021. 195 funds tracked by Wall St. Rank hold BLFS as of Q3 2024.

  • Marshall Wace reported no remaining BioLife Solutions position as of Q3 2024 after selling out during the quarter.
  • Marshall Wace sold 10,695 BioLife Solutions shares in Q3 2024, an estimated $229K.
  • Marshall Wace first reported a position in BioLife Solutions in Q4 2018 and held it in 13 quarters.
  • Marshall Wace's BioLife Solutions position peaked at $78.6M in Q2 2021.
  • 195 funds tracked by Wall St. Rank held BioLife Solutions as of Q3 2024.

Based on Marshall Wace's 13F filing for Q3 2024, filed 14 Nov 2024.